The Global "Filariasis Treatment Market" was valued at USD 33.23 Million in 2023 and is projected to reach USD 46.82 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period (2024-2030). The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Filariasis treatment involves the use of antiparasitic medications such as diethylcarbamazine (DEC), ivermectin, and albendazole to kill the filarial worms that cause the infection. Additionally, treatment may include managing symptoms and complications, such as lymphedema or elephantiasis, through measures like hygiene, exercise, and in some cases, surgery.
-
Influence of COVID-19: The impact of the COVID-19 pandemic has been considered in the market size estimation.
-
Impact of Russia-Ukraine War: The ongoing Russia-Ukraine conflict has also been factored into the market projections.
-
Forecast Period: The growth forecast spans from 2024 to 2030.
-
Growth Drivers: Factors such as increased awareness of filariasis, improved healthcare infrastructure, and advancements in medical treatments are likely to drive market growth.
-
Regional Insights: Regions with a higher prevalence of filariasis, such as parts of Africa and Asia, could see significant market activity.
-
Treatment Advances: Innovations in treatment methods, including new drug developments and combination therapies, are expected to contribute to market growth.
-
Market Challenges: Potential challenges may include limited access to healthcare in certain regions, drug resistance, and the high cost of advanced treatments.
The global key manufacturers of Filariasis Treatment include Johnson & Johnson Private Limited, Pfizer Inc., Elsai Co Ltd, Atra Pharmaceuticals, AbbVie Inc, K.A. Malle Pharmaceuticals, Unimark Remedies, Cipla and Bausch Health, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Filariasis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Filariasis Treatment. This report contains market size and forecasts of Filariasis Treatment in global, including the following market information:
- Global Filariasis Treatment Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global top five companies in 2023 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Filariasis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Filariasis Treatment Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Filariasis Treatment Market Segment Percentages, by Type, 2023 (%)
Global Filariasis Treatment Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Filariasis Treatment Market Segment Percentages, by Application, 2023 (%)
Global Filariasis Treatment Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Filariasis Treatment Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Filariasis Treatment revenues in global market, 2019-2024 (estimated), ($ millions)
- Key companies Filariasis Treatment revenues share in global market, 2023 (%)
Key Players Include:
- Johnson & Johnson Private Limited
- Pfizer Inc.
- Elsai Co Ltd
- Atra Pharmaceuticals
- AbbVie Inc
- K.A. Malle Pharmaceuticals
- Unimark Remedies
- Cipla
- Bausch Health
- Novartis AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Filariasis Treatment, market overview.
Chapter 2: Global Filariasis Treatment market size in revenue.
Chapter 3: Detailed analysis of Filariasis Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Filariasis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Filariasis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Filariasis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Filariasis Treatment Overall Market Size
2.1 Global Filariasis Treatment Market Size: 2023 VS 2030
2.2 Global Filariasis Treatment Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Filariasis Treatment Players in Global Market
3.2 Top Global Filariasis Treatment Companies Ranked by Revenue
3.3 Global Filariasis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Filariasis Treatment Companies in Global Market, by Revenue in 2023
3.5 Global Companies Filariasis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Filariasis Treatment Players in Global Market
3.6.1 List of Global Tier 1 Filariasis Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Filariasis Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Filariasis Treatment Market Size Markets, 2023 & 2030
4.1.2 Drugs
4.1.3 Vaccine
4.2 By Type - Global Filariasis Treatment Revenue & Forecasts
4.2.1 By Type - Global Filariasis Treatment Revenue, 2019-2024
4.2.2 By Type - Global Filariasis Treatment Revenue, 2025-2030
4.2.3 By Type - Global Filariasis Treatment Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Filariasis Treatment Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Filariasis Treatment Revenue & Forecasts
5.2.1 By Application - Global Filariasis Treatment Revenue, 2019-2024
5.2.2 By Application - Global Filariasis Treatment Revenue, 2025-2030
5.2.3 By Application - Global Filariasis Treatment Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Filariasis Treatment Market Size, 2023 & 2030
6.2 By Region - Global Filariasis Treatment Revenue & Forecasts
6.2.1 By Region - Global Filariasis Treatment Revenue, 2019-2024
6.2.2 By Region - Global Filariasis Treatment Revenue, 2025-2030
6.2.3 By Region - Global Filariasis Treatment Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Filariasis Treatment Revenue, 2019-2030
6.3.2 US Filariasis Treatment Market Size, 2019-2030
6.3.3 Canada Filariasis Treatment Market Size, 2019-2030
6.3.4 Mexico Filariasis Treatment Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Filariasis Treatment Revenue, 2019-2030
6.4.2 Germany Filariasis Treatment Market Size, 2019-2030
6.4.3 France Filariasis Treatment Market Size, 2019-2030
6.4.4 U.K. Filariasis Treatment Market Size, 2019-2030
6.4.5 Italy Filariasis Treatment Market Size, 2019-2030
6.4.6 Russia Filariasis Treatment Market Size, 2019-2030
6.4.7 Nordic Countries Filariasis Treatment Market Size, 2019-2030
6.4.8 Benelux Filariasis Treatment Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Filariasis Treatment Revenue, 2019-2030
6.5.2 China Filariasis Treatment Market Size, 2019-2030
6.5.3 Japan Filariasis Treatment Market Size, 2019-2030
6.5.4 South Korea Filariasis Treatment Market Size, 2019-2030
6.5.5 Southeast Asia Filariasis Treatment Market Size, 2019-2030
6.5.6 India Filariasis Treatment Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Filariasis Treatment Revenue, 2019-2030
6.6.2 Brazil Filariasis Treatment Market Size, 2019-2030
6.6.3 Argentina Filariasis Treatment Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Filariasis Treatment Revenue, 2019-2030
6.7.2 Turkey Filariasis Treatment Market Size, 2019-2030
6.7.3 Israel Filariasis Treatment Market Size, 2019-2030
6.7.4 Saudi Arabia Filariasis Treatment Market Size, 2019-2030
6.7.5 UAE Filariasis Treatment Market Size, 2019-2030
7 Filariasis Treatment Companies Profiles
7.1 Johnson & Johnson Private Limited
7.1.1 Johnson & Johnson Private Limited Company Summary
7.1.2 Johnson & Johnson Private Limited Business Overview
7.1.3 Johnson & Johnson Private Limited Filariasis Treatment Major Product Offerings
7.1.4 Johnson & Johnson Private Limited Filariasis Treatment Revenue in Global Market (2019-2024)
7.1.5 Johnson & Johnson Private Limited Key News & Latest Developments
7.2 Pfizer Inc.
7.2.1 Pfizer Inc. Company Summary
7.2.2 Pfizer Inc. Business Overview
7.2.3 Pfizer Inc. Filariasis Treatment Major Product Offerings
7.2.4 Pfizer Inc. Filariasis Treatment Revenue in Global Market (2019-2024)
7.2.5 Pfizer Inc. Key News & Latest Developments
7.3 Elsai Co Ltd
7.3.1 Elsai Co Ltd Company Summary
7.3.2 Elsai Co Ltd Business Overview
7.3.3 Elsai Co Ltd Filariasis Treatment Major Product Offerings
7.3.4 Elsai Co Ltd Filariasis Treatment Revenue in Global Market (2019-2024)
7.3.5 Elsai Co Ltd Key News & Latest Developments
7.4 Atra Pharmaceuticals
7.4.1 Atra Pharmaceuticals Company Summary
7.4.2 Atra Pharmaceuticals Business Overview
7.4.3 Atra Pharmaceuticals Filariasis Treatment Major Product Offerings
7.4.4 Atra Pharmaceuticals Filariasis Treatment Revenue in Global Market (2019-2024)
7.4.5 Atra Pharmaceuticals Key News & Latest Developments
7.5 AbbVie Inc
7.5.1 AbbVie Inc Company Summary
7.5.2 AbbVie Inc Business Overview
7.5.3 AbbVie Inc Filariasis Treatment Major Product Offerings
7.5.4 AbbVie Inc Filariasis Treatment Revenue in Global Market (2019-2024)
7.5.5 AbbVie Inc Key News & Latest Developments
7.6 K.A. Malle Pharmaceuticals
7.6.1 K.A. Malle Pharmaceuticals Company Summary
7.6.2 K.A. Malle Pharmaceuticals Business Overview
7.6.3 K.A. Malle Pharmaceuticals Filariasis Treatment Major Product Offerings
7.6.4 K.A. Malle Pharmaceuticals Filariasis Treatment Revenue in Global Market (2019-2024)
7.6.5 K.A. Malle Pharmaceuticals Key News & Latest Developments
7.7 Unimark Remedies
7.7.1 Unimark Remedies Company Summary
7.7.2 Unimark Remedies Business Overview
7.7.3 Unimark Remedies Filariasis Treatment Major Product Offerings
7.7.4 Unimark Remedies Filariasis Treatment Revenue in Global Market (2019-2024)
7.7.5 Unimark Remedies Key News & Latest Developments
7.8 Cipla
7.8.1 Cipla Company Summary
7.8.2 Cipla Business Overview
7.8.3 Cipla Filariasis Treatment Major Product Offerings
7.8.4 Cipla Filariasis Treatment Revenue in Global Market (2019-2024)
7.8.5 Cipla Key News & Latest Developments
7.9 Bausch Health
7.9.1 Bausch Health Company Summary
7.9.2 Bausch Health Business Overview
7.9.3 Bausch Health Filariasis Treatment Major Product Offerings
7.9.4 Bausch Health Filariasis Treatment Revenue in Global Market (2019-2024)
7.9.5 Bausch Health Key News & Latest Developments
7.10 Novartis AG
7.10.1 Novartis AG Company Summary
7.10.2 Novartis AG Business Overview
7.10.3 Novartis AG Filariasis Treatment Major Product Offerings
7.10.4 Novartis AG Filariasis Treatment Revenue in Global Market (2019-2024)
7.10.5 Novartis AG Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Filariasis Treatment Market Opportunities & Trends in Global Market
Table 2. Filariasis Treatment Market Drivers in Global Market
Table 3. Filariasis Treatment Market Restraints in Global Market
Table 4. Key Players of Filariasis Treatment in Global Market
Table 5. Top Filariasis Treatment Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Filariasis Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Filariasis Treatment Revenue Share by Companies, 2019-2024
Table 8. Global Companies Filariasis Treatment Product Type
Table 9. List of Global Tier 1 Filariasis Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Filariasis Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Filariasis Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Filariasis Treatment Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Filariasis Treatment Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Filariasis Treatment Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Filariasis Treatment Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Filariasis Treatment Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Filariasis Treatment Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Filariasis Treatment Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Filariasis Treatment Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Filariasis Treatment Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Filariasis Treatment Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Filariasis Treatment Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Filariasis Treatment Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Filariasis Treatment Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Filariasis Treatment Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Filariasis Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Filariasis Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Filariasis Treatment Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Filariasis Treatment Revenue, (US$, Mn), 2025-2030
Table 30. Johnson & Johnson Private Limited Company Summary
Table 31. Johnson & Johnson Private Limited Filariasis Treatment Product Offerings
Table 32. Johnson & Johnson Private Limited Filariasis Treatment Revenue (US$, Mn) & (2019-2024)
Table 33. Johnson & Johnson Private Limited Key News & Latest Developments
Table 34. Pfizer Inc. Company Summary
Table 35. Pfizer Inc. Filariasis Treatment Product Offerings
Table 36. Pfizer Inc. Filariasis Treatment Revenue (US$, Mn) & (2019-2024)
Table 37. Pfizer Inc. Key News & Latest Developments
Table 38. Elsai Co Ltd Company Summary
Table 39. Elsai Co Ltd Filariasis Treatment Product Offerings
Table 40. Elsai Co Ltd Filariasis Treatment Revenue (US$, Mn) & (2019-2024)
Table 41. Elsai Co Ltd Key News & Latest Developments
Table 42. Atra Pharmaceuticals Company Summary
Table 43. Atra Pharmaceuticals Filariasis Treatment Product Offerings
Table 44. Atra Pharmaceuticals Filariasis Treatment Revenue (US$, Mn) & (2019-2024)
Table 45. Atra Pharmaceuticals Key News & Latest Developments
Table 46. AbbVie Inc Company Summary
Table 47. AbbVie Inc Filariasis Treatment Product Offerings
Table 48. AbbVie Inc Filariasis Treatment Revenue (US$, Mn) & (2019-2024)
Table 49. AbbVie Inc Key News & Latest Developments
Table 50. K.A. Malle Pharmaceuticals Company Summary
Table 51. K.A. Malle Pharmaceuticals Filariasis Treatment Product Offerings
Table 52. K.A. Malle Pharmaceuticals Filariasis Treatment Revenue (US$, Mn) & (2019-2024)
Table 53. K.A. Malle Pharmaceuticals Key News & Latest Developments
Table 54. Unimark Remedies Company Summary
Table 55. Unimark Remedies Filariasis Treatment Product Offerings
Table 56. Unimark Remedies Filariasis Treatment Revenue (US$, Mn) & (2019-2024)
Table 57. Unimark Remedies Key News & Latest Developments
Table 58. Cipla Company Summary
Table 59. Cipla Filariasis Treatment Product Offerings
Table 60. Cipla Filariasis Treatment Revenue (US$, Mn) & (2019-2024)
Table 61. Cipla Key News & Latest Developments
Table 62. Bausch Health Company Summary
Table 63. Bausch Health Filariasis Treatment Product Offerings
Table 64. Bausch Health Filariasis Treatment Revenue (US$, Mn) & (2019-2024)
Table 65. Bausch Health Key News & Latest Developments
Table 66. Novartis AG Company Summary
Table 67. Novartis AG Filariasis Treatment Product Offerings
Table 68. Novartis AG Filariasis Treatment Revenue (US$, Mn) & (2019-2024)
Table 69. Novartis AG Key News & Latest Developments
List of Figures
Figure 1. Filariasis Treatment Segment by Type in 2023
Figure 2. Filariasis Treatment Segment by Application in 2023
Figure 3. Global Filariasis Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Filariasis Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Filariasis Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Filariasis Treatment Revenue in 2023
Figure 8. By Type - Global Filariasis Treatment Revenue Market Share, 2019-2030
Figure 9. By Application - Global Filariasis Treatment Revenue Market Share, 2019-2030
Figure 10. By Type - Global Filariasis Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Filariasis Treatment Revenue Market Share, 2019-2030
Figure 12. By Application - Global Filariasis Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Filariasis Treatment Revenue Market Share, 2019-2030
Figure 14. By Region - Global Filariasis Treatment Revenue Market Share, 2019-2030
Figure 15. By Country - North America Filariasis Treatment Revenue Market Share, 2019-2030
Figure 16. US Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Filariasis Treatment Revenue Market Share, 2019-2030
Figure 20. Germany Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 21. France Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Filariasis Treatment Revenue Market Share, 2019-2030
Figure 28. China Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. India Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Filariasis Treatment Revenue Market Share, 2019-2030
Figure 34. Brazil Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Filariasis Treatment Revenue Market Share, 2019-2030
Figure 37. Turkey Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Filariasis Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. Johnson & Johnson Private Limited Filariasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Pfizer Inc. Filariasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Elsai Co Ltd Filariasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Atra Pharmaceuticals Filariasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. AbbVie Inc Filariasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. K.A. Malle Pharmaceuticals Filariasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Unimark Remedies Filariasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Cipla Filariasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Bausch Health Filariasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Novartis AG Filariasis Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
